Adverum Biotechnologies logo
Adverum Biotechnologies ADVM
$ 4.7 0.0%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Adverum Biotechnologies Balance Sheet 2011-2024 | ADVM

Annual Balance Sheet Adverum Biotechnologies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

36 K 38.4 M 68.8 M -31.7 M -33.6 M -155 M -70.5 M -222 M -221 M -159 M -564 K 128 K -

Long Term Debt

64.6 M 93.6 M 101 M - - - - - - - - 485 K -

Long Term Debt Current

10.4 M 13.2 M 1.89 M 4.47 M 4.03 M - - - - - - - -

Total Non Current Liabilities

- - - 27.3 M 28.4 M 1.61 M 7.2 M 9.09 M 5.15 M 6.95 M 141 K 544 K -

Total Current Liabilities

24.9 M 32.2 M 21.3 M 20.9 M 19.4 M 10.7 M 10.7 M 9.9 M 6.57 M 5.47 M - - -

Total Liabilities

89.5 M 127 M 124 M 48.2 M 47.8 M 12.3 M 17.9 M 19 M 11.7 M 12.4 M 1.3 M 1.38 M -

Deferred Revenue

- - - - - - 1.85 M 1.85 M 883 K 813 K - - -

Retained Earnings

-920 M -803 M -648 M -503 M -385 M -321 M -254 M -198 M -84.2 M -36.7 M -8.87 M -3.59 M -

Total Assets

173 M 308 M 440 M 483 M 223 M 213 M 202 M 235 M 264 M 162 M 1.08 M 386 K -

Cash and Cash Equivalents

75 M 68.4 M 34.2 M 62.4 M 65.9 M 155 M 70.5 M 222 M 221 M 159 M 564 K 357 K -

Book Value

83.5 M 182 M 316 M 434 M 175 M 201 M 184 M 216 M 253 M 149 M -218 K -997 K -

Total Shareholders Equity

83.5 M 182 M 316 M 434 M 175 M 201 M 184 M 216 M 253 M 149 M -8.21 M -3.47 M -

All numbers in USD currency

Quarterly Balance Sheet Adverum Biotechnologies

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

62.6 M 63.3 M 64 M 65.2 M 65.8 M 71.3 M 93.6 M 94.5 M 99.2 M 100 M 101 M 118 M 125 M 25.7 M 26.2 M 26.2 M 26.2 M 26.2 M 28.2 M 28.2 M 28.2 M 28.2 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

90.3 M 85.8 M 85.5 M 94.1 M 110 M 118 M 127 M 124 M 131 M 124 M 124 M 145 M 147 M 46.7 M 48.2 M 48.2 M 48.2 M 48.2 M 47.8 M 47.8 M 47.8 M 47.8 M 12.3 M 12.3 M 12.3 M 12.3 M 17.9 M 17.9 M 17.9 M 17.9 M 19 M 19 M 19 M 19 M 11.7 M 11.7 M 11.7 M 11.7 M 12.4 M 12.4 M 12.4 M 12.4 M 1.3 M 1.3 M 1.3 M - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - 70 K 753 K 1.25 M 1.85 M 1.85 M 1.85 M 1.85 M 1.85 M 1.85 M 1.85 M 1.85 M 883 K 883 K 883 K 883 K 813 K 813 K 813 K 813 K - - - - - - - - - - - -

Retained Earnings

-990 M -963 M -945 M -896 M -863 M -832 M -803 M -770 M -730 M -686 M -648 M -614 M -575 M -531 M -503 M -503 M -503 M -503 M -385 M -385 M -385 M -385 M -321 M -321 M -321 M -321 M -254 M -254 M -254 M -254 M -198 M -198 M -198 M -198 M -84.2 M -84.2 M -84.2 M -84.2 M -36.7 M -36.7 M -36.7 M -36.7 M -8.87 M -8.87 M -8.87 M - - - - - - - - -

Total Assets

234 M 254 M 268 M 197 M 241 M 276 M 308 M 332 M 375 M 407 M 440 M 491 M 526 M 462 M 483 M 483 M 483 M 483 M 223 M 223 M 223 M 223 M 213 M 213 M 213 M 213 M 202 M 202 M 202 M 202 M 235 M 235 M 235 M 235 M 264 M 264 M 264 M 264 M 162 M 162 M 162 M 162 M 1.08 M 1.08 M 1.08 M - - - - - - - - -

Cash and Cash Equivalents

92.9 M 127 M 150 M 105 M 111 M 67.6 M 68.4 M 84.4 M 91.9 M 89.7 M 34.2 M 33 M 47.3 M 45.4 M 62.4 M 62.4 M 62.4 M 62.4 M 65.9 M 65.9 M 65.9 M 65.9 M 155 M 155 M 155 M 155 M 70.5 M 70.5 M 70.5 M 70.5 M 222 M 222 M 222 M 222 M 221 M 221 M 221 M 221 M 159 M 159 M 159 M 159 M 564 K 564 K 564 K - 357 K - - - 1.12 M - - -

Book Value

144 M 168 M 182 M 103 M 131 M 158 M 182 M 208 M 244 M 283 M 316 M 346 M 379 M 415 M 434 M 434 M 434 M 434 M 175 M 175 M 175 M 175 M 201 M 201 M 201 M 201 M 184 M 184 M 184 M 184 M 216 M 216 M 216 M 216 M 253 M 253 M 253 M 253 M 149 M 149 M 149 M 149 M -218 K -218 K -218 K - - - - - - - - -

Total Shareholders Equity

144 M 168 M 182 M 103 M 131 M 158 M 182 M 208 M 244 M 283 M 316 M 346 M 379 M 415 M 434 M 434 M 434 M 434 M 175 M 175 M 175 M 175 M 201 M 201 M 201 M 201 M 184 M 184 M 184 M 184 M 216 M 216 M 216 M 216 M 253 M 253 M 253 M 253 M 149 M 149 M 149 M 149 M -8.21 M -8.21 M -8.21 M - -3.47 M - - - -1.74 M - - -

All numbers in USD currency